Diazyme Laboratories announces acquisition of Carolina Liquid Chemistries
The integration of CLC into Diazyme's operations aims to leverage cost-effective, reliable products alongside proprietary technologies, creating synergies for laboratories of all sizes.
Diazyme Laboratories, Inc. has acquired the business of Carolina Liquid Chemistries Corporation (CLC), according to an announcement.
CLC is an FDA registered manufacturer, and value-added reseller of chemistry systems and reagents. Founded in 1994 and headquartered in Greensboro, North Carolina, CLC's business will be integrated into Diazyme’s operations.
Diazyme Laboratories’ Managing Director, Dr. Chong Yuan, gave the following statement regarding the acquisition: “Carolina Liquid Chemistries’ cost-effective and reliable products will complement Diazyme’s proprietary enzyme and immunoassay technologies, creating synergies that will benefit laboratories of all sizes. This strategic acquisition positions us to enhance our diagnostic capabilities and deliver even more comprehensive solutions to reference and clinical laboratories and improve patient outcomes.”
